{"id":401105447,"name":"BLUEBIRD STRATEGIES","slug":"bluebird-strategies","totalIncome":1865000,"filings":59,"yearlyIncome":[{"year":2019,"income":112000},{"year":2020,"income":565000},{"year":2021,"income":500000},{"year":2022,"income":430000},{"year":2024,"income":180000},{"year":2025,"income":78000}],"clients":["FAEGRE BAKER DANIELS CONSULTING (ON BEHALF OF GLOBAL DOWN SYNDROME FOUNDATION)","MYRIAD GENETICS, INC.","MYOTONIC","THERMO FISHER SCIENTIFIC INC","PEAR THERAPEUTICS","GLOBAL DOWN SYNDROME FOUNDATION","THE PEGGY LILLIS FOUNDATION","LUMINOPIA, INC.","CLICK THERAPEUTICS, INC.","BOEHRINGER INGELHEIM USA CORPORATION","NCATS ALLIANCE","DIGITAL THERAPEUTICS ALLIANCE","CELLTRION USA, INC.","FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) SOCIETY","ATA ACTION"],"lobbyists":["JOHN BRENNAN"],"issues":["BUD","MED","MMM","HCR","DEF","VET"],"clientCount":15,"years":[2019,2020,2021,2022,2024,2025]}